FILKRI Trademark

Trademark Overview

On Thursday, May 20, 2021, a trademark application was filed for FILKRI with the United States Patent and Trademark Office. The USPTO has given the FILKRI trademark a serial number of 90723273. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Wednesday, April 10, 2024. This trademark is owned by Accord BioPharma, Inc.. The FILKRI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceuticals used for stimulating white blood cell production
filkri

General Information

Serial Number90723273
Word MarkFILKRI
Filing DateThursday, May 20, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateWednesday, April 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 8, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceuticals used for stimulating white blood cell production
Translation of Words in MarkThe wording "FILKRI" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 17, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAccord BioPharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDurham, NC 27617
Party NameAccord BioPharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Trademark Events

Event DateEvent Description
Monday, May 24, 2021NEW APPLICATION ENTERED
Tuesday, August 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 1, 2022ASSIGNED TO EXAMINER
Wednesday, February 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 2, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 8, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 2, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, May 3, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 2, 2022SOU EXTENSION 1 FILED
Wednesday, November 2, 2022SOU EXTENSION 1 GRANTED
Thursday, April 27, 2023SOU TEAS EXTENSION RECEIVED
Friday, November 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 27, 2023SOU EXTENSION 2 FILED
Thursday, April 27, 2023SOU EXTENSION 2 GRANTED
Monday, October 23, 2023SOU TEAS EXTENSION RECEIVED
Monday, October 23, 2023SOU EXTENSION 3 FILED
Monday, October 23, 2023SOU EXTENSION 3 GRANTED
Wednesday, October 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 10, 2024SOU EXTENSION 4 FILED
Wednesday, April 10, 2024SOU TEAS EXTENSION RECEIVED
Saturday, April 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 10, 2024SOU EXTENSION 4 GRANTED
Thursday, May 9, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 9, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 9, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 9, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, May 9, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 9, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, April 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

filkri white blood cell production stimulating used preparations namely pharmaceuticals pharmaceutical